|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, less allowance of $5.0 million and $4.9 million, respectively | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Current assets of discontinued operations (Note 3) | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Trade names and trademarks | ||||||||||||||||||||
| Net book value | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Equity method investments (Note 9) | ||||||||||||||||||||
| Deferred tax assets, long-term | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Long-term assets of discontinued operations (Note 4) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Accrued employee compensation and benefits | ||||||||||||||||||||
| Convertible notes, net | ||||||||||||||||||||
| Long-term debt, current portion | ||||||||||||||||||||
| Asset-based credit facilities | ||||||||||||||||||||
| Operating lease liabilities, short-term | ||||||||||||||||||||
| Construction advances | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Current liabilities of discontinued operations (Note 3) | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||||
| Operating lease liabilities, long-term | ||||||||||||||||||||
| Deemed landlord financing obligations | ||||||||||||||||||||
| Financing lease liabilities, long-term | ||||||||||||||||||||
| Total financing lease liabilities, long-term | ||||||||||||||||||||
| Deferred taxes, net | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Long-term liabilities of discontinued operations (Note 4) | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value, 3.0 million shares authorized, none issued and outstanding at both June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, $0.01 par value, 360.0 million shares authorized, and 186.2 million shares issued at both June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings (accumulated deficit) | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock (in shares) | ||||||||||||||||||||
| Less: Common stock held in treasury, at cost, 7.1 million and 2.3 million shares as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
| Common stock, issued (in shares) | ||||||||||||||||||||
Loading...
